Drug Development in the Digital Age
joint with Digital Paths to Improve Human Health
Scientific Organizers: Chris Benko and Qi Liu
Date: April 05 - 08, 2021
Location: Snowbird Resort, Snowbird, UT, USA
In this digital age, innovative techniques such as machine learning (ML)/artificial intelligence (AI) algorithms can help us unlock the power of the mind-blowing amounts of data generated at an ever-accelerating pace. This represents new opportunities in drug development and precision medicine. However, it also brings new challenges such as privacy and data sharing ethical considerations. Interpreting such output in terms of what matters to patients is also of concern because the data collected requires a well-defined patient context to be relevant. The goal of this meeting is to discuss the emerging technology/opportunities, such as the use of AI/ML in drug discovery/repurposing and analyzing imaging/genomics data, the use of digital biomarkers, real-world data and decentralized trials to facilitate drug development/precision medicine, as well as the challenges and potential solutions related to data sharing, ethical considerations and patient relevance.
Registration for this meeting is not open yet, it will open later in January 2020